Ethinylestradiol/norethisterone acetate (Redirected from Anovlar)
Combination of | |
---|---|
Ethinylestradiol | Estrogen |
Norethisterone acetate | Progestogen |
Clinical data | |
Trade names | Estrostep, Loestrin, Microgestin, others[1] |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | By mouth (pill) |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID |
Ethinylestradiol/norethisterone acetate, also known as ethinyl estradiol/norethindrone acetate, is a combination of ethinylestradiol and norethisterone acetate which is used as birth control.[1] Ethinylestradiol is an estrogen while norethisterone acetate is a progestin.[1] It is taken by mouth.[1]
In 2016 it was the 55th most prescribed medication in the United States with more than 14 million prescriptions.[2]
Brand names
Brand names include Anovlar, Blisovi, Cumorit, Estrostep, FemHRT, Fyavolv, Gildess, Junel, Larin, Leribane, Loestrin, Mibelas, Microgestin, Minastrin, Norlestrin, Primodos, Taytulla, Tri-Legest
In addition, the combination is marketed in the United States under the brand name FemHRT for use in hormone replacement therapy for menopausal symptoms.[3]
See also
- Estradiol/norethisterone acetate
- Oral contraceptive formulations
- List of combined sex-hormonal preparations
References
- ^ a b c d "Estrogen-Progestin Combinations Monograph for Professionals". Drugs.com. AHFS. Retrieved 28 December 2018.
- ^ "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.
- ^ "Drug Approval Package: Femhrt (Norethindrone Acetate & Ethinyl Estradiol) NDA# 21-065". www.accessdata.fda.gov. Retrieved 28 December 2018.
| |||||
---|---|---|---|---|---|
Comparison | |||||
Behavioral |
| ||||
Barrier and / or spermicidal | |||||
Hormonal (formulations) |
| ||||
Anti-estrogen |
| ||||
Post-intercourse | |||||
Intrauterine device | |||||
Sterilization |
| ||||
Experimental | |||||
Long-acting reversible contraception (LARC) |
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Androgens | |||||||||||||
Estrogens | |||||||||||||
Progestogens |
|
| |||||||
---|---|---|---|---|---|---|---|
PR |
| ||||||
mPR (PAQR) |
| ||||||
|
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.
|